Processa Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCSA and other ETFs, options, and stocks.

About PCSA

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. 

CEO
George K. Ng
CEOGeorge K. Ng
Employees
10
Employees10
Headquarters
Hanover, Maryland
HeadquartersHanover, Maryland
Founded
2011
Founded2011
Employees
10
Employees10

PCSA Key Statistics

Market cap
3.70M
Market cap3.70M
Price-Earnings ratio
-0.09
Price-Earnings ratio-0.09
Dividend yield
Dividend yield
Average volume
8.84M
Average volume8.84M
High today
$0.3182
High today$0.3182
Low today
$0.252
Low today$0.252
Open price
$0.28
Open price$0.28
Volume
3.75M
Volume3.75M
52 Week high
$3.10
52 Week high$3.10
52 Week low
$0.15
52 Week low$0.15

People also own

Based on the portfolios of people who own PCSA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.